Literature DB >> 9973236

Immunohistochemical localization of calmodulin-dependent cyclic phosphodiesterase in the human brain.

S Lal1, R K Sharma, C McGregor, R J Macaulay.   

Abstract

The amplification of cyclic nucleotide 'second messenger' signals within neurons is controlled by phosphodiesterases which are responsible for their degradation. Calmodulin-dependent phosphodiesterase (CaMPDE) is an abundant enzyme in brain which carries out this function. For the first time, we have localized CaMPDE in the normal human brain at various ages, using a mononoclonal antibody designated A6. This antibody was generated using standard techniques, purified, and applied to tissue sections. Autopsy specimens of human brain with no neuropathological abnormalities were selected representing a range of pre- and postnatal ages. Sections of various brain regions were evaluated for immunoreactivity, graded as nil, equivocal, or definite. We demonstrated definite CaMPDE immunohistochemical staining in neocortex, especially in neurons in layers 2 and 5. There was definite neuronal immunoreactivity in the hippocampus, and in the subiculum. The striatum had definite patchy neuronal staining. Definite terminal staining in the globus pallidus externa and substantia nigra pars reticulata outlined resident neurons, interpreted as axonal terminal staining. Cerebellar Purkinje cells showed definite immunoreactivity. In the developing brain, definite immunohistochemical staining was seen in the cerebellar external granular layer. The expression of CaMPDE in specific subsets of neurons suggests they may correlate with cells having dopaminergic innervation and/or high levels of neuronal integration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9973236     DOI: 10.1023/a:1020975913007

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  29 in total

1.  Dopamine receptor subtypes colocalize in rat striatonigral neurons.

Authors:  D J Surmeier; J Eberwine; C J Wilson; Y Cao; A Stefani; S T Kitai
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

2.  D1 and D2 dopamine receptor mRNA in rat brain.

Authors:  D M Weiner; A I Levey; R K Sunahara; H B Niznik; B F O'Dowd; P Seeman; M R Brann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

Review 3.  Midbrain dopamine system electrophysiological functioning: a review and new hypothesis.

Authors:  B S Bunney; L A Chiodo; A A Grace
Journal:  Synapse       Date:  1991-10       Impact factor: 2.562

4.  Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia.

Authors:  D M Weiner; A I Levey; M R Brann
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 5.  Pharmacological and molecular basis for dopamine D-2 receptor diversity.

Authors:  M Memo
Journal:  Mol Neurobiol       Date:  1990 Fall-Winter       Impact factor: 5.590

Review 6.  Neuronal phosphoproteins. Mediators of signal transduction.

Authors:  P Greengard
Journal:  Mol Neurobiol       Date:  1987 Spring-Summer       Impact factor: 5.590

7.  Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB.

Authors:  K K Yamamoto; G A Gonzalez; W H Biggs; M R Montminy
Journal:  Nature       Date:  1988-08-11       Impact factor: 49.962

8.  Expression of striatal D1 dopamine receptors coupled to inositol phosphate production and Ca2+ mobilization in Xenopus oocytes.

Authors:  L C Mahan; R M Burch; F J Monsma; D R Sibley
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

9.  D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.

Authors:  C R Gerfen; T M Engber; L C Mahan; Z Susel; T N Chase; F J Monsma; D R Sibley
Journal:  Science       Date:  1990-12-07       Impact factor: 47.728

10.  Gene expression and cAMP.

Authors:  Y Nagamine; E Reich
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

View more
  3 in total

1.  Phosphodiesterase 1B knock-out mice exhibit exaggerated locomotor hyperactivity and DARPP-32 phosphorylation in response to dopamine agonists and display impaired spatial learning.

Authors:  Tracy M Reed; David R Repaske; Gretchen L Snyder; Paul Greengard; Charles V Vorhees
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

Review 2.  Distribution of calcium-binding proteins in the cerebellum.

Authors:  Enrico Bastianelli
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

Review 3.  Selective phosphodiesterase inhibitors: a promising target for cognition enhancement.

Authors:  Olga A H Reneerkens; Kris Rutten; Harry W M Steinbusch; Arjan Blokland; Jos Prickaerts
Journal:  Psychopharmacology (Berl)       Date:  2008-08-16       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.